trending Market Intelligence /marketintelligence/en/news-insights/trending/b-OAKhDFc7cAkfc9p6OILg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Inovalon Holdings teams up with biotech company Amgen

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Fintech Intelligence Digital Newsletter: May 2021

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Inovalon Holdings teams up with biotech company Amgen

Inovalon Holdings Inc. has inked an agreement with Amgen Inc. to target value-based contracts between payers and life sciences companies.

Under the pact, Inovalon and its wholly owned subsidiary, Avalere Health, will use their data and analytics to further develop outcome-based contracts based on the value of Amgen's products. They will specifically work on rheumatoid arthritis, a chronic, high-cost autoimmune disease affecting more than two million Americans.